But following his election win this week it is looking increasingly likely that won’t happen and Donald Trump will once again ...
To date, the Food and Drug Administration (FDA) has approved six chimeric antigen receptor (CAR) T cell therapy products targeting CD19 and BCMA for B-cell lymphomas, leukemias and multiple myeloma, ...
As cancer cells grow, they pump out metabolic byproducts such as lactic acid into the tumor microenvironment. Exhausted T ...
TCRclub integrates scRNA-seq and scTCR-seq data by local harmony to identify functionally similar T cell groups, termed ...
UC San Francisco treated its first brain cancer patient with an experimental new CAR-T therapy discovered and manufactured at ...
Multiple players are exploring whether modalities designed to combat B cell malignancies can be repurposed against lupus, ...
Allogene Therapeutics has reported phase 1 data on its solid tumor CAR-T, linking the off-the-shelf cell therapy candidate to ...
CAR-T cell therapy, a marvel of bioengineering, takes a patient’s own immune cells and reprograms them to attack cells ...
Hydrogen fuel cell electric vehicles may be envisioned as the future workhorse of a decarbonized longhaul freight sector, but ...
Membraneless organelles, also called biomolecular condensates, are changing how scientists think about protein chemistry, ...
The mother of a teenager with sickle cell disease said medical treatment for the genetic blood disorder was a "postcode ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback